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Abstract
Introduction: Fire smoke inhalation a recognized etiologic factor of airway injuries. The objective of this study was evaluation of 
serum high-mobility group box 1 (HMGB1) protein concentration in subjects exposed to fire smoke (SEFS). 
Material and methods: The study group consisted of 40 consecutive patients admitted to the Toxicology Unit, Lodz, Poland after 
exposure to fire smoke. Serum HMGB1 concentrations were measured upon admission to hospital and rechecked on the 2nd and 
on the day of discharge. Patients also underwent routine toxicological diagnostic procedures applied in case of those exposures, 
such as carboxyhaemoglobin (COHb) levels and urinary thiocyanate concentrations. The same diagnostic tests were performed 
in 10 healthy volunteers not exposed to smoke of the control group. 
Results: The average serum SEFS concentration of HMGB1 protein was not significantly higher on admission in comparison with 
the respective values recorded on the 2nd day and on the day of discharge. The mean serum level of HMGB1 protein of exposed 
group was higher than that one in the control group, however the difference was not statistically significant. The highest con-
centration of HMGB1 protein was noted in serum of 28 subjects exposed to fire smoke reporting at least one symptom and the 
difference was statistically significant in a comparison with the control group. 
Conclusion: As indicated, an acute exposure to smoke may lead to transient increase of HMGB1 in serum in exposed subjects. 
Further studies are necessary in order to confirm the importance of this protein in pathogenesis of acute airway injury due to 
exposure to fire smoke. 
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Streszczenie
Wstęp: Narażenie na dymy pożarowe jest udokumentowaną przyczyną toksycznego uszkodzenia układu oddechowego. Celem 
badania była ocena stężeń białka HMGB1 w surowicy osób narażonych na dymy pożarowe.
Materiał i metody: grupę badaną stanowiło 40 osób narażonych na dymy pożarowe, które zostały przyjęte na oddział toksykologii
w Łodzi. Stężenia białka HMGB1 oznaczono w dniu przyjęcia do szpitala oraz ponownie w drugim i ostatnim dniu hospitalizacji. 
U pacjentów wykonano także badania toksykologiczne zlecane przy tego typu narażeniu: stężenie karboksyhemoglobiny i stężenie 
rodanków w moczu. Podobny panel badań zlecono u 10 zdrowych osób (grupa kontrolna) nienarażonych na dymy pożarowe. 
Wyniki: Stężenia białka HMGB1 w grupie pacjentów narażonych na dymy pożarowe nie różniły się istotnie statystycznie 
w analizowanych dniach hospitalizacji, jak i z wartością wymienionego parametru ocenianego w surowicy osób z grupy kontrolnej. 
Stężenie białka HMGB1 w surowicy krwi 28 osób narażonych na dymy pożarowe zgłaszających obecność co najmniej jednego 
objawu chorobowego w pierwszej dobie hospitalizacji było istotnie wyższe niż w materiale biologicznym osób z grupy kontrolnej.
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Wnioski: Prezentowane wyniki badań mogą wskazywać na specyficzność działania HMGB1 jako mediatora reakcji zapalnej 
w drogach oddechowych osób narażonych na czynniki drażniące uwalniane podczas pożaru.
Słowa kluczowe: białko HMGB1, uszkodzenie płuc, pożar
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Introduction
Exposure to the variety of chemical agents 
emitted during fire accidents may result in acute 
airway injuries [1]. Nitrogen and sulphur dioxides, 
aldehydes, carbon monoxide (CO) and halogenated 
hydrocarbons constitute the major volatile toxins 
released during the combustion and pyrolysis 
processes [1]. Such exposures may lead to the 
development of inflammation of upper and lower 
airways. According to Abraham et al. HMGB1 
protein is a mediator of acute inflammatory lung 
injury [2]. Intratracheal instillation of HMGB1 in 
mice produces acute injury that is manifested by 
neutrophil accumulation, lung edema and increase 
in pulmonary cytokine levels, such as: TNF, IL-1b 
and MIP-2 [2]. This pro-inflammatory cytokine is 
actively released from such cells as: macrophages, 
monocytes, NK cells, dendritic cells, endothelial 
cells and platelets [3]. HMGB1 is also released into 
the extracellular compartment by necrotic and da-
maged cells. Then it consequently modulates the 
innate immune response as a nuclear protein [4]. 
The question addressed by the present study 
was whether the extent of acute respiratory tract 
injury caused by acute exposure to fire smoke cor-
responds with alterations in serum HMGB1 levels. 
Material and methods
Subjects and exposure
Forty consecutive patients from a large town 
were admitted to the Toxicology Unit between 
January and December 2009 directly after acci-
dental exposure to fire smoke (subjects exposed 
to fire smoke, SEFS). The main source of exposure 
was uncontrolled fire in dwelling house or flat, 
resulting from careless handling stoves, ciga-
rettes or charcoal grills. Patients spent at least 
15−20 minutes in the atmosphere containing a 
mixture of toxic gases and fumes produced by 
the combustion and pyrolisis of some plastics, 
wood, fabric and other substrates. No assesment 
of smoke particles diameter was performed at the 
place of accident. 
The average age in the examined group was 
49.75 ± 16.48 years. Sixteen of them (40%) were 
smokers at the time of study or in the past. 
The control group consisted of 10 healthy in-
dividuals and 5 of them (50%) smoked cigarettes 
at the moment of study or before.
The Regional Bioethical Committee appro-
ved the study protocol and all the participants 
submitted their written consent prior enrolling 
them to the study.
Clinical symptoms 
Each patient was examined for the presence 
and intensity of following symptoms: cough, 
wheeze, sputum production, exertional dyspnoe, 
and ocular, nasal and pharyngeal symptoms as 
well. The intensity of these symptoms was evalu-
ated using scoring: 0 points for lack of symptom, 
1 point — for mild expression, 2 points — for 
strong manifestation. 
Laboratory tests 
Carboxyhemoglobin (COHb) level and uri-
nary thiocyanate levels were evaluated on admis-
sion to the hospital. 
HMGB1 determination
HMGB1 in serum was measured using com-
mercially available enzyme-linked immunosor-
bent assay (ELISA) (IBL International GMBH, Ger-
many). Sensitivity of the method was 1.0 ng/ml.
Statistical analysis
Results are expressed as mean values ± SD. 
Results of toxicological tests at the 1st day of 
hospitalization in the group of SEFS and control 
group were compared using the Mann-Whitney test. 
The results of tests for HMGB1 performed at 
the 1st, 2nd day and the day of discharge for the 
studied group were matched against those one 
obtained in the control group using the Tam-
hane’s test.
The p values < 0.05 were considered sig-
nificant. 
Results
In the studied group of 40 subjects, twenty 
eight patients (70%) complained of at least one 
symptom associated with the exposure. The most 
frequently observed initial clinical pathology 
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in this group was a manifestation of lower air-
ways pathology that was reported by 21 patients 
(52.5% of studied cohort). Nasal or pharyngeal 
symptoms were recorded in 14 (35%) cases and 
symptoms associated with conjunctivitis in 9 
(22.5%) cases (all data presented in the article 
published in 2013 [5]). The intensity of symp-
toms on admission was characterised as mild by 
18 subjects and as abundant was marked by 10 
patients, respectively. Only 5 subjects reported 
the intensity of analyzed symptoms as mild on 
the day of discharge. 
Discussed symptoms occurred in the group of 
16 smokers with different frequency. Particularly, 
ocular ones were reported by 6 (37.5%) subjects, 
those of upper airways (nasal/pharyngeal) by 10 
(62.5%) cases and dyspnea/cough by 8 (50%) sub-
jects, respectively. Six smokers did not complain 
of any symptom due to exposure to fire on the 
day of admission (the first day of hospitalization). 
The presence of thermal injury to the face 
and/or nose was reported in 8 (20%) subjects 
among the analyzed group of forty patients ad-
mitted to hospital immediately after accidental 
exposure to fire smoke.
The average level of COHb in the studied group 
constituted 6.77 ± 6.37% of total haemoglobin, 
whereas in the control group it was 1.63 ± 0.57%, 
respectively. The mean concentrations of thiocya-
nates in the group of SEFS were 5.84 ± 7.12 mg/l. 
COHb levels and thiocyanates concentrations 
were significantly higher in the group of SEFS 
compared to control (p < 0.05) (all data presented 
in the article published in 2013 [5]). 
The highest concentration of HMGB1 in the 
examined group of 40 subjects exposed to fire 
smoke was noted at the admission day (the 1st day 
of hospitalization) — 3.41 ± 4.48 ng/ml. It tended 
to decrease gradually to 2.86 ± 1.7 ng/ml on the 
second day of hospitalization and subsequently to 
2.17 ± 1.93 ng/ml on the day of discharge. Mean 
serum HMGB1 levels in the hospitalized patients 
did not differ significantly from those found in 
serum of the controls (Fig. 1). 
The concentration of HMGB1 in the serum of 
28 symptomatic subjects from the exposed group 
was higher comparing to that of 12 asymptomatic 
subjects from the same group, however the ob-
served difference did not reach statistical signif-
icance (Fig. 2). The symptomatic group included 
all — 8 (28.57%) patients with thermal injury of 
the face and/or nose. 
There was observed statistically significant 
difference between the concentration of HMGB1 
in the serum of 28 symptomatic subjects from the 
Figure 2. The concentration of HMGB1 in serum of subjects exposed 
to fire smoke (SEFS) (asymptomatic and with at least one symptom) 
and in the controls
Rycina 2. Stężenie HMGB1 w surowicy osób narażonych na dymy 
pożarowe (osoby bez objawów klinicznych i z co najmniej jednym 
objawem chorobowym) oraz w grupie kontrolnej
Figure 1. The concentration of HMGB1 in serum of subjects exposed 
to fire smoke (SEFS) and in the controls
Rycina 1. Stężenie HMGB1 w surowicy osób narażonych na dymy 
pożarowe oraz w grupie kontrolnej
exposed group comparing to the concentration of 
this protein in the control group (p < 0.05) (Fig. 2). 
Discussion
A number of studies have dealt with the 
search for diagnostic tools measuring non-invasi-
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vely the extent of lung inflammation for over the 
last decades [6, 7]. There are data showing that 
HMGB1 can be inducer of inflammation [8, 9]. 
High HMGB1 concentrations were found in the 
pulmonary epithelial lining fluid of patients with 
sepsis [10]. This protein was found as a mediator of 
burn injury [11] and rheumatoid arthritis [12]. Some 
studies have focused on promoting role of HMGB1 
in cancer development and progression [13]. 
HMGB1 is a nuclear non-histone DNA-bind-
ing protein that serves as a structural co-factor 
for transcriptional regulation in somatic cells 
[14, 15].
There are two pathway mechanisms for cells 
to liberate HMGB1 into the extracellular milieu. 
The first one is a passive release from damaged or 
necrotic cells, and in this scenario HMGB1 acts as 
intracellular marker responsible for recognizing tis-
sue damage and initiating reparative responses [16]. 
Another scenario assumes that HMGB1 may be 
actively secreted from immune cells and works as 
a proinflammatory cytokine [17]. In our study, 
the highest concentration of HMGB1 in the group 
of 40 subjects exposed to fire smoke was noted 
at the admission day (the 1st day of hospitaliza-
tion) and it tended to decrease gradually on the 
second day of hospitalization and on the day of 
discharge, however the average concentration of 
HMGB1 did not differ significantly between ana-
lyzed days of hospitalization in patients exposed 
to fire smoke. No significant difference was also 
found between HMGB1 concentrations in serum 
of exposed subjects to fire smoke and the control 
ones. The average concentration of HMGB1 in the 
control group was significantly lower than that 
one measured on the first day of hospitalization in 
28 symptomatic subjects. It is important to notice 
that in the aforesaid group there were all subjects 
with thermal injury of the face and/or nose. As 
mentioned above some authors [11] reported 
that up-regulation of HMGB1 expression may be 
involved in the pathogenesis of multiple organ 
damage secondary to major burns as a result of 
releasing endogenous endotoxins. 
The higher increase of HMGB1 concentration 
in our study directly after the exposure to fire 
smoke may be explained by damage of cells in the 
respiratory tract, which resulted from exposure to 
the toxic agents emitted during the fire. 
Unfortunately no data about the nature of 
inhaled smoke directly in the atmosphere at the 
place of accident were obtainable. 
Relatively low levels of COHb and lack of 
clinical signs of carbon monoxide poisoning ob-
served in the presented study may suggest that 
in our group this kind of exposure did not play 
an important role, so that fact resulted in the 
lack of increasing HMGB1 concentrations on the 
following days of hospitalization. 
The most frequent complaints at admission 
in the group of subjects exposed to fire included 
lower airway symptoms and similar findings were 
described by other authors [18, 19].
The group of SEFS showed significantly 
higher COHb level and thiocynate concentration 
on admission compared with the control group. 
These two gases are released during uncontrolled 
fire at varied concentrations depending on the 
kind of substrates undergoing combustion and 
they may contribute to overall toxicity of fire 
smoke [20−22]. 
Conclusion
As indicated, acute exposure to smoke may 
lead to transient increase of HMGB1 in serum of 
exposed subjects. Further studies are necessary 
to confirm the important role of this protein in 
pathogenesis of acute airway injury. 
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